Skip to main content
. 2022 Sep 14;8:384. doi: 10.1038/s41420-022-01177-0

Fig. 6. MiR-16-5p suppresses GC progression by inhibiting ABL2 expression.

Fig. 6

A Transwell (scale bars = 100 μm), B colony-formation, C wound healing (scale bars = 50 μm), D CCK-8, and E apoptosis assays revealed the effect of miR-16-5p inhibitor on promoting cell migration and growth, while it inhibited apoptosis, and ABL2 siRNA mitigated it. F As revealed by Western blotting assay, miR-16-5p inhibitor increased ABL2 expression. G and H ABL2 silencing within MGC-803 cells decreased N-Cadherin, Vimentin, Snail, YAP, and p-SMAD2/3 levels, while no change was observed for SMAD2/3. I–K miR-16-5p upregulation can alleviate GC cells biological behaviors with ABL2 downregulation. L MiR-16-5p mimics reduces the role of Arg lentiviral activation particles. M and N Western blotting detected the effects of miR-16-5p mimics and Arg lentiviral activation particles effects on EMT and SMAD2/3, p-SMAD2/3, YAP, and p-YAP protein levels. *p < 0.05, **p < 0.01, ***p < 0.001.